$2.26
0.89% today
NYSE, May 16, 08:50 pm CET
ISIN
US67080N1019
Symbol
NUVB
Sector
Industry

Nuvation Bio Inc - Ordinary Shares - Class A Stock price

$2.24
+0.22 10.89% 1M
-0.39 14.83% 6M
-0.42 15.79% YTD
-1.06 32.12% 1Y
-1.81 44.69% 3Y
-7.76 77.60% 5Y
-7.76 77.60% 10Y
NYSE, Closing price Thu, May 15 2025
+0.07 3.23%
ISIN
US67080N1019
Symbol
NUVB
Sector
Industry

Key metrics

Market capitalization $762.19m
Enterprise Value $311.92m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 28.46
P/S ratio (TTM) P/S ratio 69.54
P/B ratio (TTM) P/B ratio 1.81
Revenue (TTM) Revenue $10.96m
EBIT (operating result TTM) EBIT $-206.36m
Free Cash Flow (TTM) Free Cash Flow $-157.55m
Cash position $461.68m
EPS (TTM) EPS $-2.34
P/E forward negative
P/S forward 54.49
EV/Sales forward 22.30
Short interest 15.93%
Show more

Is Nuvation Bio Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,785 stocks worldwide.

Nuvation Bio Inc - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast:

8x Buy
100%

Analyst Opinions

8 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast:

Buy
100%

Financial data from Nuvation Bio Inc - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
11 11
-
100%
- Direct Costs 10 10
4,714% 4,714%
92%
0.85 0.85
505% 505%
8%
- Selling and Administrative Expenses 95 95
244% 244%
870%
- Research and Development Expense 111 111
70% 70%
1,012%
-205 -205
120% 120%
-1,874%
- Depreciation and Amortization 0.94 0.94
348% 348%
9%
EBIT (Operating Income) EBIT -206 -206
121% 121%
-1,883%
Net Profit -606 -606
780% 780%
-5,533%

In millions USD.

Don't miss a Thing! We will send you all news about Nuvation Bio Inc - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nuvation Bio Inc - Ordinary Shares - Class A Stock News

Neutral
Business Wire
3 days ago
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that new data from a matching-adjusted indirect comparison study evaluating taletrectinib versus entrectinib in ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC) will be presented in a poster session at ISPOR 2025, t...
Neutral
Business Wire
4 days ago
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global oncology company tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, and Philippe Sauvage, Chief Financial Officer of Nuvation Bio, will participate in fireside chats at three upcoming investor conferences: H.C. Wai...
Neutral
Seeking Alpha
5 days ago
Nuvation Bio Inc. (NYSE:NUVB ) Q1 2025 Earnings Call May 7, 2025 4:30 PM ET Company Participants J.R. DeVita - Investor Relations David Hung - Founder, President and Chief Executive Officer Colleen Sjogren - Chief Commercial Officer Philippe Sauvage - Chief Financial Officer Conference Call Participants Gregory Renza - RBC Capital Markets Kaveri Pohlman - Clear Street Soumit Roy - Jones Researc...
More Nuvation Bio Inc - Ordinary Shares - Class A News

Company Profile

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Head office United States
CEO David Hung
Employees 220
Founded 2018
Website www.nuvationbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today